U.S. Citigroup, Nike, Tesla
June 20 (Reuters) -Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Citigroup, Nike and Tesla, on Thursday.
HIGHLIGHTS
* Bread Financial Holdings Inc BFH.N: Evercore ISI raises to in line from underperform |
* Citigroup C.N: KBW raises target price to $69 from $66 |
* Lennar Corp LEN.N: Evercore ISI cuts target price to $237 from $238 |
* Nike Inc NKE.N: Barclays cuts target price to $109 from $114 |
* Tesla Inc TSLA.O: RBC cuts target price to $227 from $293 |
Following is a summary of research actions on U.S. companies reported by Reuters on Thursday. Stock entries are in alphabetical order.
* Adma Biologics Inc ADMA.O: Mizuho raises target price to $14 from $12 |
* Agnico Eagle Mines Ltd AEM.N: BMO cuts target price to $77 from $79 |
* Allstate Corp ALL.N: Evercore ISI cuts target price to $178 from $180 |
* Arista Networks Inc ANET.N: BofA Global Research raises PT to $380 from $320 |
* Ball Corp BALL.N: Wells Fargo cuts target price to $64 from $69 |
* Ball Corporation BALL.N: Wells Fargo cuts target price to $64 from $69 |
* Bank of Hawaii Corp BOH.N: Jefferies cuts target price to $53 from $55 |
* Bread Financial Holdings Inc BFH.N: Evercore ISI raises target price to $45 from $42 |
* Bread Financial Holdings Inc BFH.N: Evercore ISI raises to in line from underperform |
* Cardlytics CDLX.O: BofA Global Research reinstates coverage with neutral rating; PT $11 |
* Charles Schwab Corp SCHW.N: Deutsche Bank cuts target price to $81 from $83 |
* Citigroup C.N: KBW raises target price to $69 from $66 |
* Constellation Brands Inc STZ.N: JP Morgan cuts target price to $291 from $296 |
* Constellation Brands Inc STZ.N: UBS cuts target price to $315 from $320 |
* Crocs Inc CROX.O: BofA Global Research raises price objective to $187 from $160 |
* CVS Health CVS.N: Barclays raises target price to $65 from $63 |
* Darden Restaurants Inc DRI.N: Piper Sandler cuts target price to $163 from $167 |
* Delek US Holdings Inc DK.N: Mizuho cuts target price to $27 from $31 |
* Dow Inc DOW.N: Jefferies cuts target price to $55 from $60 |
* Emergent Biosolutions Inc EBS.N: Benchmark raises target price to $8 from $5 |
* Energy Transfer LP ET.N: JP Morgan raises target price to $20 from $19 |
* Enphase Energy Inc ENPH.O: JP Morgan cuts target price to $124 from $128 |
* Esperion Therapeutics ESPR.O: BofA Global Research cuts PT to $2.5 from $2.9 |
* Esperion Therapeutics ESPR.O: BofA Global Research cuts to underperform from neutral |
* Fidelity National Information Services FIS.N: Barclays raises PT to $88 from $85 |
* First Solar FSLR.O: Barclays raises target price to $280 from $228 |
* Freeport-Mcmoran Inc FCX.N: Citigroup raises target price to $52 from $46 |
* General Motors Co GM.N: UBS raises target price to $61 from $58 |
* Healthequity Inc HQY.O: Wells Fargo raises target price to $110 from $107 |
* HF Sinclair Corp DINO.N: Mizuho cuts target price to $61 from $64 |
* Humana HUM.N: Barclays raises target price to $370 from $326 |
* Illumina Inc ILMN.O: Guggenheim cuts target price to $138 from $159 |
* Insmed Inc INSM.O: JP Morgan raises target price to $72 from $55 |
* International Seaways Inc INSW.N: Stifel raises target price to $68 from $66 |
* KB Home KBH.N: Barclays raises target price to $78 from $77 |
* KB Home KBH.N: Evercore ISI raises target price to $86 from $78 |
* KB Home KBH.N: KBW raises target price to $77 from $74 |
* KB Home KBH.N: Wedbush raises target price to $67 from $64 |
* Lennar Corp LEN.N: Barclays cuts target price to $177 from $180 |
* Lennar Corp LEN.N: Barclays cuts target price to $177 from $180 |
* Lennar Corp LEN.N: BofA Global Research cuts price objective to $171 from $189 |
* Lennar Corp LEN.N: BTIG cuts target price to $175 from $177 |
* Lennar Corp LEN.N: Evercore ISI cuts target price to $237 from $238 |
* Lennar Corp LEN.N: JP Morgan cuts target price to $154 from $157 |
* Longboard Pharmaceuticals Inc LBPH.O: Evercore ISI raises PT to $57 from $44 |
* Marathon Petroleum Corp MPC.N: Mizuho cuts target price to $201 from $203 |
* Micron Technology Inc MU.O: Wells Fargo raises target price to $190 from $135 |
* Mirum Pharmaceuticals Inc MIRM.O: Stifel raises target price to $66 from $48 |
* Nextera Energy Inc NEE.N: JP Morgan raises target price to $90 from $76 |
* Nike Inc NKE.N: Barclays cuts target price to $109 from $114 |
* Nike Inc NKE.N: Barclays cuts target price to $109 from $114 |
* Nike Inc NKE.N: Citigroup cuts target price to $115 from $125 |
* Nike Inc NKE.N: JP Morgan cuts target price to $116 from $122 |
* Nvidia NVDA.O: Stifel adjusts PT to $165 from $1140 to reflect 10-for-1 stock split |
* Ocular Therapeutix Inc OCUL.O: TD Cowen raises target price to $11 from $7 |
* Patterson Companies Inc PDCO.O: Morgan Stanley cuts target price to $28 from $30 |
* Paycom Software Inc PAYC.N: TD Cowen cuts target price to $147 from $170 |
* Paycor HCM Inc PYCR.O: TD Cowen cuts target price to $13 from $19 |
* Paylocity Holding Corp PCTY.O: TD Cowen cuts target price to $153 from $180 |
* PBF Energy Inc PBF.N: Mizuho cuts target price to $54 from $58 |
* Phillips 66 PSX.N: Mizuho cuts target price to $160 from $162 |
* Polaris Inc PII.N: BofA Global Research cuts price objective to $86 from $95 |
* Prelude Therapeutics Inc PRLD.O: Barclays cuts to underweight from equal-weight |
* Quaker Houghton KWR.N: Jefferies cuts target price to $185 from $209 |
* Robinhood Markets Inc HOOD.O: Deutsche Bank raises target price to $20 from $19 |
* Sage Therapeutics Inc SAGE.O: JP Morgan cuts target price to $23 from $28 |
* Samsara Inc IOT.N: BofA Global Research initiates coverage with buy rating; PT $37 |
* Shattuck Labs Inc STTK.O: H.C. Wainwright cuts target price to $16 from $28 |
* Southern Copper Corp SCCO.N: Citigroup raises target price to $100 from $73.24 |
* Spirit Aerosystems SPR.N: Benchmark cuts to hold from buy |
* Tesla Inc TSLA.O: RBC cuts target price to $227 from $293 |
* Transdigm Group Inc TDG.N: Deutsche Bank raises target price to $1524 from $1435 |
* TransUnion TRU.N: BofA Global Research raises to buy from neutral |
* Valero Energy Corp VLO.N: Mizuho cuts target price to $171 from $176 |
* Vericel Corp VCEL.O: TD Cowen initiates coverage with buy rating; target price $55 |
* Veris Residential Inc VRE.N: Evercore ISI cuts target price to $16 from $17 |
* Virgin Galactic Holdings SPCE.N: Morgan Stanley raises target price to $35 from $1.75 |
* Virios Therapeutics Inc VIRI.O: Maxim Group initiates coverage with buy rating; PT $1 |
* Zentalis Pharmaceuticals Inc ZNTL.O: Morgan Stanley cuts target price to $8 from $38 |
* Zentalis Pharmaceuticals Inc ZNTL.O: Morgan Stanley cuts to equal-weight |
* Zentalis Pharmaceuticals Inc ZNTL.O: UBS cuts target price to $5 from $28 |
* Zentalis Pharmaceuticals Inc ZNTL.O: UBS cuts to neutral from buy |
* Ziprecruiter Inc ZIP.N: JP Morgan cuts target price to $10 from $12 |
(Compiled by Bengaluru Newsroom)
</body></html>İlgili varlıklar
En son haberler
Bildirim: XM Group şirketlerinin her biri yalnızca gerçekleştirme hizmeti ve online yatırım platformumuza erişim sağlar. Herhangi bir kişinin web sitesinde bulunan veya web sitesi üzerinden sağlanan içeriği görüntülemesine ve/veya kullanmasına izin vermek, bu hizmeti değiştirmek veya genişletmek amaçlı değildir ve bu hizmeti ne değiştirir ne de genişletir. Bu tür erişim ve kullanım her zaman şunlara tabidir: (i) Şartlar ve Koşullar; (ii) Risk Uyarıları ve (iii) Tam Bildirim. Bu nedenle bu tür içerikler yalnızca genel bilgi amacıyla sağlanır. Özellikle, online yatırım platformumuzun içeriklerinin finans piyasalarında herhangi bir işleme girmek için bir teşvik veya bir teklif olmadığını lütfen dikkate alın. Herhangi bir finans piyasasında yatırım yapmak sermayeniz için önemli düzeyde risk taşır.
Online yatırım platformumuzda yayınlanan tüm materyaller yalnızca eğitim/bilgilendirme amaçlıdır ve finansal tavsiye, yatırım vergisi veya yatırım tavsiyesi ve önerileri ya da yatırım fiyatlarımızın kaydı veya herhangi bir finansal enstrümanda işlem yapılması için bir teklif veya teşvik ya da talep edilmemiş finansal promosyonları içermez ve içerdiği şeklinde bir değerlendirme yapılmamalıdır.
Görüşler, haberler, araştırma, analizler, fiyatlar, diğer bilgiler veya bu web sitesinde bulunan üçüncü taraf sitelere verilen bağlantılar gibi her türlü üçüncü taraf içeriğin yanı sıra XM tarafından hazırlanan içerik de “olduğu gibi” esasına göre, genel piyasa yorumu olarak sağlanır ve bir yatırım tavsiyesi oluşturmaz. Herhangi bir içeriğin yatırım araştırması olarak yorumlanmasıyla ilgili olarak, içeriğin bağımsız yatırım araştırmasını desteklemek üzere tasarlanmış yasal gerekliliklere uygun hazırlanmadığını ve bu amacın güdülmediğini, aynı şekilde ilgili yasalar ve mevzuatlar kapsamında pazarlama iletişimi olarak değerlendirileceğini dikkate almalı ve kabul etmelisiniz. Buradan erişebileceğiniz Bağımsız Olmayan Yatırım Araştırması Bildirimimizi ve yukarıdaki bilgilerle ilgili Risk Uyarımızı okuduğunuzdan ve anladığınızdan emin olun.
